Sri Balaji Vidyapeeth, Deemed to be University has developed a keen interest in widening its wings in industrial collaboration especially in pharma arena, as per the suggestions of Vice-Chancellor, SBV, Prof. Subhash Chandra Parija. In view of this a brief ceremony held on 26th April 2019 at SBV under the Chairmanship of Prof. Subhash Chandra Parija. During this ceremony, a Letter of Intent was signed by the authorities of both the sides (SBV and Pondchy Pharmaceuticals, Reltson Health Care and Huntra Labs) in the presence of Prof. M. Ravishankar, Dean – MGMCRI, Mrs. Asha Suresh Babu, General Manager (Admin.), SBV, Prof. Partha Nandi, Vice-Principal (Students), MGMCRI, Dr. Jagan Mohan R, Manager – MI, Dr. Sarath Chandran, Principal- School of Pharmacy and Mr. Joseph Naresh, Deputy Registrar, SBV.
Prof. Subhash Chandra Parija complemented the efforts of SBV and said that “the academic world has the freedom that attracts many scientists. Discoveries in basic science are often made in academia and lead to the subsequent development of practical uses. Drug discoveries such as finding a new activity of a compound ( i.e., pleiotropic effect) may be an unexpected discovery of a study with a different purpose. Such exploratory work in basic science can ultimately lead to much scientific progress. As the work is done in a transparent environment, academics traditionally enjoy not only the discovery of these results but also the dissemination of the results in the form of peer-reviewed publications. In spite of the many positives of academic research, finding and obtaining funding for basic science is difficult, so researchers spend substantial time writing grants and seeking out collaborations with researchers to bring in new areas of expertise and to improve the odds of obtaining funding. These researchers are savvy about collaborating within their institution and frequently with other institutions to find resources and further their scientific cause. Even so, achieving the funding required to conduct research can be one of the most difficult obstacles to overcome in the academic world.”
He further added that “it would seem that collaboration with industry could provide an avenue through which the breadth of research expertise on a particular area of study could be expanded and funding for the research could be obtained. These benefits could be obtained along with an additional benefit, which is that the industry partner would bring experience in moving a discovery through the various phases necessary to obtain market approval”.
